BeStock  
Stocks › Biotechnology › ATAI

AtaiBeckley ATAI

US equityBiotechnology
$0.00 +$0.00 (0.00%)
Market closed · Nov 20, 9:30 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap–
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.4%last 6 reports
Closed higher4 of 667% of the time
Best reaction+11.0%
Worst reaction-13.9%

Stock move on the day after each report

+8.3%2021/Q2-13.9%2021/Q3-1.5%2021/Q4+11.0%2022/Q1+2.2%2022/Q2+7.7%2022/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2022/Q310 Nov 2022None±25.7%+7.72%Within range
2022/Q215 Aug 2022None±25.1%+2.18%Within range
2022/Q116 May 2022None±31.6%+10.99%Within range
2021/Q430 Mar 2022Pre Market±33.2%-1.48%Within range
2021/Q315 Nov 2021Pre Market±16.7%-13.87%Within range
2021/Q216 Aug 2021Pre Market–+8.30%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.70M+137.0% YoY
Operating profit-$41.72M-65.3% YoY
Net profit-$32.55M-17.3% YoY
Diluted EPS-$0.09+35.7% YoY
Free cash flow-$35.27M-148.0% YoY
Operating cash flow-$35.27M

Revenue, last 8 quarters

$40.0KSep '24$-5,000Dec '24$1.6MMar '25$719.0KJun '25$749.0KSep '25$1.1MDec '25$954.0KMar '26$1.7MJun '26

Net profit, last 8 quarters

$-26.3MSep '24$-39.0MDec '24$-26.5MMar '25$-27.7MJun '25$-61.1MSep '25$-544.8MDec '25$-29.8MMar '26$-32.5MJun '26

Profitability & balance sheet

Operating margin-3,122.6%
Net margin-14,941.7%
Return on equity-417.5%
Return on assets-294.4%
Return on invested capital-403.9%
Current ratio8.58
Liabilities / assets33.4%
Cash & investments$225.81M
Total debt$1.57M
Net cash (debt)$224.24M

Discussion

No comments yet — be the first to weigh in on ATAI.

Sign in to join the discussion.

Scroll to Top